Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma

Sorafenib, a multi-tyrosine kinase inhibitor, is a standard treatment for advanced hepatocellular carcinoma (HCC). The present study was undertaken to determine whether the growth and metastasis of HCC were influenced in mice receiving sorafenib prior to implantation with tumors, and to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiang-Bo, Sun, Hui-Chuan, Zhang, Ke-Zhi, Jia, Qing-An, Bu, Yang, Wang, Miao, Chai, Zong-Tao, Zhang, Quan-Bao, Wang, Wen-Quan, Kong, Ling-Qun, Zhu, Xiao-dong, Lu, Lu, Wu, Wei-Zhong, Wang, Lu, Tang, Zhao-You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568028/
https://www.ncbi.nlm.nih.gov/pubmed/23409093
http://dx.doi.org/10.1371/journal.pone.0055945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568028/
https://www.ncbi.nlm.nih.gov/pubmed/23409093
http://dx.doi.org/10.1371/journal.pone.0055945

Ejemplares similares